All opinions contained within pieces presented on this page are published at the discretion of the author and/or publisher. The DETOUR System is an investigational device limited by United States law to investigational use. The DETOUR System is not available for sale.
DETOUR I: Percutaneous bypass procedure successful at 12 months
7/1/2018
Twelve-Month Data Presented for PQ Bypass' Detour System
6/28/2018
PQ Bypass Touts 1-year Detour Study Data
6/28/2018
PQ Bypass Reports Positive 12-Month Results for Entirely New Procedure to Treat Extremely Long SFA Lesions in Patients with PAD
6/28/2018
PQ Bypass: PQ Bypass Announces First Patient Treated in Landmark DETOUR II Trial Evaluating New Treatment Approach for Clogged Leg Arteries
2/22/2018
PQ Bypass Receives IDE to Initiate DETOUR II Pivotal Trial
12/13/2017
PQ Bypass Reports Positive Results for the Novel DETOUR System in Patients With Tough to Treat Long Blockages in the Femoropopliteal Artery
9/12/2017
PQ Bypass touts subset analysis data from DETOUR system trial
9/12/2017
PQ Bypass to Unveil New Data From DETOUR I at VIVA 17
9/8/2017
PQ Bypass: Recipient of Frost & Sullivan's 2017 European Peripheral Artery Disease Interventions Technology Innovation Award
8/31/2017
PQ Bypass Earns Frost & Sullivan's European Technology Innovation Award for Its Proprietary DETOUR System for Percutaneous Bypass
8/31/2017
PQ Bypass Earns Frost & Sullivan's European Technology Innovation Award
8/31/2017
Sanarus Technologies Appoints Senior Medtech Executive Heather Simonsen to Board of Directors
4/24/2017
Vascular News: PQ Bypass announces CE Mark for DETOUR percutaneous bypass technologies
3/14/2017
Medical Design Technology: PQ Bypass Announces CE Mark for DETOUR Percutaneous Bypass Technologies
3/14/2017
Medical Device Network: PQ Bypass's DETOUR percutaneous technologies secure CE mark
3/14/2017
FierceBiotech: PQ Bypass gets CE Mark for peripheral artery disease tech
3/13/2017
Mass Device Today: PQ Bypass wins CE Mark for trio of PAD tools
3/13/2017
Endovascular Today: CE Mark Granted for PQ Bypass' Detour Percutaneous Bypass Technologies
3/13/2017
PQ Bypass: PQ Bypass Announces CE Mark for DETOUR Percutaneous Bypass Technologies
3/13/2017
TCTMD: Percutaneous Bypass for Long, Complex SFA Lesions Holds Up Well to 6 Months: DETOUR I Study
2/10/2017
PQ Bypass Announces Positive Results From DETOUR I Study at LINC 2017
1/24/2017
PQ Bypass: PQ Bypass Announces Schedule of Presentations at LINC 2017
1/19/2017
PQ Bypass: Mass Device Today: Personnel Moves Sept. 15, 2016
9/15/2017
PQ Bypass: Early Findings Presented for PQ Bypass’ Endovascular Femoropopliteal Artery Bypass Procedure - Endovascular Today
9/14/2016